PAM
Panagora Asset Management’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,231
| Closed | -$2.45M | – | 1140 |
|
|
2024
Q3 | $2.45M | Buy |
+27,231
| New | +$2.45M | 0.01% | 499 |
|
|
2022
Q3 | – | Sell |
-20,415
| Closed | -$782K | – | 1439 |
|
|
2022
Q2 | $782K | Buy |
20,415
+7,695
| +60% | +$295K | 0.01% | 988 |
|
|
2022
Q1 | $526K | Buy |
+12,720
| New | +$526K | ﹤0.01% | 1189 |
|
|
2020
Q4 | – | Sell |
-7,291
| Closed | -$519K | – | 2808 |
|
|
2020
Q3 | $519K | Sell |
7,291
-3,555
| -33% | -$253K | ﹤0.01% | 1152 |
|
|
2020
Q2 | $892K | Buy |
+10,846
| New | +$892K | 0.01% | 973 |
|